Journey Medical Corp expected to post a loss of 24 cents a share - Earnings Preview

Journey Medical

12/05/2025 21:06

Journey Medical Corp DERM.OQ DERM.O is expected to show a fall in quarterly revenue when it reports  results on May 14 for the period ending March 31 2025

The Scottsdale Arizona-based  company is expected to report a 7.5% decrease in revenue to $12.055 million from $13.03 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.

​LSEG's mean analyst estimate for Journey Medical Corp is for a loss of 24 cents per share.

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."

The mean earnings estimate of analysts was unchanged in the last three months. ​

Wall Street's median 12-month price target for Journey Medical Corp is $9.75​, above​ its last closing price of $6.88. ​​​

Previous quarterly performance (using preferred earnings measure in US dollars). ​

QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-0.35
-0.15
Beat
57.4
Sep. 30 2024
-0.14
-0.15
-0.17
Missed
-15.3
Jun. 30 2024
-0.14
-0.14
-0.17
Missed
-18.6​
Mar. 31 2024
-0.23
-0.23
-0.53
Missed
-125.5
​​Dec. 31 2023
-0.09
-0.08
-0.12
Missed
-56.5
Sep. 30 2023
-0.11
-0.15
0.80
Beat
616.1​
Jun. 30 2023
-0.35
-0.33
-0.29
Beat
13.4
Mar. 31 2023
-0.45
-0.45
-0.57
Missed
-27.6

This summary was machine generated May 12 at 20:06 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)